Nov 14, 2023 / 09:30PM GMT
Operator
Ladies and gentlemen, thank you for standing by, and welcome to Onconova Therapeutics third quarter 2023 financial results and business update conference call. (Operator instructions) As a reminder, this call is being recorded today, November 14, 2023.
At this time, I would like to turn the call over to Bruce Mackle of LifeSci Advisors.
Bruce Mackle - LifeSci Advisors - IR
Thank you, operator, and welcome, everyone, to Onconova's third quarter 2023 financial results and business update conference call. Earlier this afternoon, Onconova issued a press release reporting its financial results and business progress. If you have not yet seen this press release, it is available in the Investors and Media section of the company's website at www.onconova.com.
Following my introduction, we will hear from Onconova's President and CEO, Dr Steven Fruchtman; Chief Medical Officer, Dr Victor Moyo; and Chief Operating Officer and Chief Financial Officer, Mark Guerin; Onconova's VP of Global
Q3 2023 Onconova Therapeutics Inc Earnings Call Transcript
Nov 15, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers